NKF 2009 Spring Clinical Meetings

Online Abstract Submission Form - Step 1

Submission Fee $40

Submission Deadline December 1,2009

Abstract Submission Instructions/Information

Format

1. The abstract should be typed single-spaced to fit standard abstract measurements using type no smaller than 10 point (12 cpi). The abstract’s title should be typed in CAPITAL LETTERS and should clearly represent the nature of the investigation. The title should be followed in lowercase letters by the authors’ first and last names, affiliation (if applicable), city, state, and country. Underline the primary author’s name (one primary author per abstract). Omit degrees, titles, institutional appointments, street address, zip codes, and research grant support. Do not leave spaces between the title and the body of the abstract or between paragraphs. Indent paragraphs three spaces. The abstract file should be saved as: primary authors last name_first word in the title, e.g., Zucker_Effects.

2. Please ensure that your abstract is the correct length (must fit on one page within the margins specified). Set the margins to the following using Microsoft Word: Top 1"; Bottom 4"; Left 1"; Right 3.5"

3. Use of standard abbreviations is desirable, e.g., RBC. Use kg., gm., mg., ml., L, and %. Place a special or unusual abbreviation in parentheses after the full word the first time it appears. Use numerals to indicate numbers except to begin sentences. Do not use subtitles, e.g., Methods, Results.

4. Simple tables or graphs may be included; however, they must fit within the designated abstract space. Note: Average chart comes out postage stamp size in abstract publications.

5. Please use common font such as Helvetica, Times or Courier.

6. Your abstract must conform to the above guidelines, as incorrect formatting will result in disqualification.

Body of Abstract

1. Organize the body of the abstract as follows:

Acceptance / Publication

1. Abstracts previously published or presented at a national/international meeting prior to the NKF 2009 Spring Clinical Meetings will not be accepted.

2. Authors will receive notification of receipt of abstract via e-mail. This notification does not imply that the abstract has been reviewed and accepted. Subsequent correspondence to the primary author will be sent in January 2009 with notification of acceptance/rejection status.

3. Accepted physician abstracts will be considered for publication in the American Journal of Kidney Diseases. Accepted dietitian abstracts will be considered for publication in the Journal of Renal Nutrition. Accepted nurse, technician, nurse practitioner and physician assistant, abstracts will be considered for publication in Advances in Chronic Kidney Disease . Accepted social worker abstracts will be considered for publication in the Journal of Nephrology Social Work

4. Acceptance of an abstract does not waive the NKF 2009 Spring Clinical Meetings registration fee. Please note that you must register for the NKF 2009 Spring Clinical Meetings in order to present your abstract.

Additional Information

1. The abstract will appear exactly as submitted including any, errors, misspellings, etc.

2. There is no limit to the number of abstracts an author may submit.

3. Please note, each abstract submitted requires a separate fee.

Allied Health Professionals

Allied health professionals are encouraged to submit abstracts reflecting identification of and solutions to issues impacting patient care.

Research Fellows/Young Investigator code:

Primary Author
First Name:
Last Name:
Credentials:
Mailing Address:
Street and Number:
 
City:
State/Province:
Country:
Zip Code/Postal Code:
E-mail:
Phone Number:
Fax Number:

Discipline

Physician Physician Assistant
Nurse Dietitian
Nurse Practitioner Social Worker
Technician Other (Please specify) 
Pharmacist

Primary Work/Practice Setting

Private Practice Dialysis Center Hospital
Academic Medical Center Transplant Center Industry
Other (Please specify) 

Area of Specialty

Research Peritoneal Dialysis Transplantation
Hemodialysis Primary Care General Nephrology
CKD Care Hypertension Epidemiology & Outcomes
Other (Please specify) 

Disclosure of Interest/Funding
Was this research funded by a pharmaceutical or device company? Yes No
If yes, do you have a financial relationship with this company? Yes No
The presenter and authors must identify any financial interests in products or processes involved in their research. This includes stock ownership, membership on an advisory board or board of directors, corporate-supported research, speakers, or other substantive relationships. (If none, write "none." If left blank, the interpretation will be "none.")

Abstract Topic

Hemodialysis: Anemia
Hemodialysis: Mineral Metabolism
Hemodialysis: Other
Acute Kidney Injury/ICU Medicine
Peritoneal Dialysis
Home Hemodialysis
Glomerular Diseases
Hypertension
Hereditary Kidney Disease/PKD
Diabetic Nephropathy
Transplantation
Electrolyte and Acid Base Abnormalities
Chronic Kidney Disease
Kidney Stones
Other (Please specify) 

Key Words

Identify up to six key words that best describe the content of your abstract:
1.  4. 
2.  5. 
3.  6. 

Abstract Title (Complete title of your abstract)

The author affirms that the material herein has not been previously published or presented at any national meeting, that any animal studies conform to the "Guiding Principles in the Care and Use of Animals" of the American Physiological Society, and that any human experimentation has been conducted according to a protocol approved by the institutional committee on ethics of human investigation or, if no such committee exists, that it conforms to the principles of the Declaration of Helsinki of the World Medical Association (CLINICAL RESEARCH 14:193, 1966).

The author(s) transfers all copyright ownership of the named abstract to the National Kidney Foundation.
I agree with the above statement
Signature: Checking this box is an indication of the primary author/submitter.

   

Back to top